RNA 43.65 (+0.92%)
US05370A1088BiotechnologyBiotechnology

Avidity Biosciences (RNA) Stock Highlights

43.65 | +0.92%
2024-11-21 01:35:52
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Statistics

Range Today
42.21 44.64
Volume Today 655.14K
Range 1 Year
5.68 56
Volume 1 Year 351.56M
Range 3 Year
4.82 56
Volume 3 Year 756.27M
Range 10 Year
4.82 56
Volume 10 Year 859.44M

Highlights

Market Capitalization 5.62B (mid)
Floating Shares 101.93M
Current Price 43.65
Price To Earnings -16.09
Price To Revenue 413.1
Price To Book 3.83
Earnings Per Share -2.9
Payout Ratio 0%

Performance

Latest +0.92%
1 Month -12.63%
3 Months -3.19%
6 Months +45.45%
1 Year +579.91%
3 Years +56.56%
5 Years +64.72%
10 Years +64.72%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.